How Do Anabolic Substances Work? - Episode 8: Biological Dose and the Body's Response

1. The labeled dose is not the same thing as the biological dose

In pharmacology, the word dose appears to point to one thing: how much substance was administered. Biologically, that is only the beginning. A dose must be absorbed, distributed, metabolized, and eliminated. The fraction that reaches tissues, the time for which it remains available, and the concentration at the site of action shape biological exposure. That is why two people receiving the same amount can have different concentrations, effects, and adverse responses.

For androgens, this distinction is essential. A molecule may circulate in blood, enter tissues, be converted into active or inactive metabolites, and generate effects that do not line up perfectly with plasma concentration. Clinical pharmacology therefore distinguishes dose-response relationships from exposure-response relationships because dose is only one step in the chain.

2. What is a dose-response relationship?

A dose-response relationship describes how a biological effect changes as exposure to a substance rises or falls. In the simplest form, greater exposure may increase an effect up to a point. But the curve is not necessarily linear. In many pharmacological systems, the response rises rapidly at first and then approaches a plateau.

That plateau matters because the body does not provide an unlimited number of receptors, signaling capacity, enzymatic capacity, or physiological reserve. Emax models capture the idea that a given system has a maximum estimated response and that further increases in exposure do not necessarily produce proportionally larger effects.

3. Dose, concentration, and exposure are not synonyms

Dose is the amount administered. Concentration is the amount present in a particular volume or biological compartment at a given time. Exposure is a broader concept describing how much and for how long the organism is subjected to the substance; in pharmacokinetics, the area under the concentration-time curve, AUC, is a classic measure of total exposure.

This distinction explains why the same total amount administered through different formulations can generate different biological profiles. Cmax may differ, Tmax may differ, and AUC may differ. The biological response can therefore depend not only on total amount, but also on how concentration rises and falls over time.

4. The receptor is not a simple on-off switch

For androgens, the androgen receptor is a central component, but it should not be imagined as a switch that produces one fixed effect instantly. A ligand binds the receptor, the complex changes state, interacts with intracellular machinery, and influences gene expression. The final outcome depends on tissue, cofactors, metabolic state, and the physiological history of the organism.

The FDA describes Emax models as tools for linking concentration or exposure to response intensity and notes that relationships between receptor occupancy and observed response can be nonlinear. In simple terms, a rise in concentration does not mean that every additional unit produces the same additional effect.

5. EC50 and Emax: two concepts that appear throughout pharmacology

Emax represents the maximum estimated effect within a particular model. EC50 represents the concentration associated with half of that model's maximum effect. These concepts are useful for comparing dose-response relationships, but they are not a practical dosing recipe and should never be transferred automatically from one outcome to another.

A drug can have a different exposure-efficacy relationship from its exposure-adverse-effect relationship. Different tissues or biological processes can also have different thresholds and curves. That is why the idea of one perfect dose that maximizes all benefits while minimizing all risks is pharmacologically unrealistic.

6. The biological threshold: when does an effect become visible?

Some biological responses become detectable only after exposure enters a certain range. In other systems, activity exists even at low concentrations, but the change is difficult to measure. An apparent threshold can therefore reflect both biology and the sensitivity of the measurement method.

In physiology, a threshold is not necessarily a perfectly sharp wall. It is more useful to think of it as a region in which the signal becomes strong enough to generate a detectable change. This matters when measuring strength, muscle mass, hemoglobin, or metabolic markers.

7. Why does the response not increase forever?

Biological systems have limits. Receptors can become occupied, signaling pathways can become saturated, enzymes have finite capacity, and physiological adaptation can alter sensitivity to a signal. Some processes also start from a relatively high baseline and therefore have less room to increase.

For this reason, a dose-response curve may contain a range in which increasing exposure produces substantial changes and a later range in which the response approaches a plateau. This is one reason that more is not synonymous with more effective.

8. An effect can keep changing even when concentration is no longer rising

Some pharmacodynamic effects are rapid, while others are slow. With an androgen, changes in gene expression, protein synthesis, and tissue remodeling do not all occur at the exact moment plasma concentration rises. This creates a difference between drug concentration and effect dynamics.

This delay means that two measurements taken at different times may tell different stories. A plasma peak can pass before a structural effect is fully expressed, and some effects can persist after concentration has already declined.

9. Testosterone provides a clear example of dose-dependent response

A classic study in healthy young men used graded doses of testosterone enanthate after suppressing endogenous testosterone production. Over 20 weeks, fat-free mass, muscle volume, strength, and power increased in relation to testosterone concentrations, while different androgen-dependent processes did not follow identical relationships. The authors explicitly showed that different androgen-dependent functions can have different dose-response relationships.

This example is important because it demonstrates two ideas at once: some effects are dose dependent, but there is no single universal curve for every testosterone effect. The same androgen system can affect lean mass, strength, hemoglobin, lipids, and other functions differently.

10. More testosterone does not mean the same increase for every outcome

In the graded-dose study, fat-free mass increased in a dose-dependent manner at the higher exposure levels, and strength and power also followed testosterone-dependent relationships. At the same time, some outcomes such as sexual function or PSA did not show the same simple relationship over the studied range. The finding illustrates how differently individual components of the body can respond.

Pharmacologically, this is functional selectivity of response. It does not mean that a substance becomes selectively beneficial simply because the user wants a particular outcome. It means that the body contains multiple systems with different sensitivities, thresholds, and capacities.

11. The muscle response is not only a receptor problem

For hypertrophy and muscular performance, much more than androgen receptor occupancy matters. Amino-acid availability, energy status, mechanical loading, recovery, sleep, endocrine state, inflammation, and many other processes contribute. A pharmacological signal can alter the anabolic environment, but the final result is produced by the whole system.

That is why the same androgen exposure can produce different outcomes in two athletes with different training programs, diets, sleep patterns, or physiological states. Biology is not a calculator that returns the same result for the same input.

12. Individual variability is part of pharmacology, not an error

Age, body composition, liver and kidney function, transport proteins, enzyme activity, genetics, and exposure history can alter both concentrations and responses. Even in controlled studies, individuals do not respond identically.

This is why clinical studies report means, ranges, and between-person variability. The mean is useful for a population, but it does not perfectly predict what will happen in one specific organism.

13. Tolerance and adaptation can change the curve

In some systems, repeated exposure can change the response. Receptors and signaling pathways may be upregulated or downregulated, and the body can alter production of endogenous hormones or substrates. With exogenous androgens, suppression of the hypothalamic-pituitary-gonadal axis is an example of a physiological response that changes the endocrine environment.

Therefore, a dose-response relationship should not be imagined as a frozen curve. It can depend on exposure duration and the biological state in which the person exists.

14. Desensitization does not mean the substance became inactive

When biological adaptation occurs, the response to the same concentration may change. This does not necessarily mean that the molecule has lost pharmacological activity. It may mean that the downstream system has adjusted. In simple language, the same key can produce a different result if the mechanism receiving the signal has changed state.

15. Blood concentration is not the concentration in every tissue

A blood test provides valuable information, but it is not a perfect window into every tissue. Hormones such as testosterone undergo local conversion, and intracrine activity can allow tissues to generate local androgenic or estrogenic signals that are not fully represented by a single plasma value.

This links directly to earlier episodes on aromatization, DHT, and metabolites. The administered dose can be the same, plasma concentration can be similar, and tissue-level outcome can still vary.

16. The same dose can mean different exposure

Bioavailability, absorption, protein binding, volume of distribution, metabolism, and clearance all influence how much and how long a substance remains available. Two people receiving the same dose can therefore reach different concentration-time profiles.

Modern pharmacology therefore asks not only «what was the dose?» but also «what was the exposure?». Dose is the input to the system; exposure and response describe what happened afterward.

17. Performance effects and adverse effects do not have to share the same curve

This is one of the most important ideas in performance pharmacology. If a desired effect rises with exposure, it does not follow that every unwanted effect rises at the same rate. Some may have steeper curves, others flatter curves, and some may appear at exposures where the observable benefit is still modest.

From this perspective, a dose-response curve never tells us by itself whether an exposure is good or bad. Pharmacological assessment requires separate consideration of efficacy, safety, and the context of the patient or athlete.

18. Why pharmacology cannot be reduced to a universal formula

It is tempting to reduce everything to an equation: more substance equals more strength. But such a model ignores pharmacokinetics, receptors, metabolites, adaptation, training, and individual variability. The same exposure can also produce different effects over time.

In research, mathematical models are useful precisely because they can describe this complexity. They do not eliminate variability; they quantify it and make it easier to analyze.

19. The sigmoid curve and the plateau region

A sigmoid Emax curve is one of the classic forms used to describe response. At low exposure, the effect may be small; in an intermediate range, small exposure changes can produce larger response changes; and at high exposure, the response approaches Emax.

The concept helps explain why a difference between two exposures can matter greatly in one part of a curve and relatively little in another. The exact curve, however, must be estimated for the specific effect and population being studied rather than assumed from a generic graph.

20. Strength is not a pure pharmacological biomarker

A strongman does not produce maximal force through one molecule. Maximal strength is influenced by muscle mass, motor-unit recruitment, coordination, technique, anthropometry, fatigue, leverage, and neural adaptation. An androgenic agent may modify some of these components directly or indirectly, but it cannot be conceptually separated from the rest of the system.

Testosterone studies have shown a dose-dependent association with leg-press strength and power, while fatigability did not change in the same way over the studied range. Again, the result shows that different dimensions of performance have distinct response relationships.

21. What does «response» mean in practice?

Response can mean a molecular change, a laboratory marker, a change in body composition, a functional change, or a clinical outcome. In pharmacology, endpoint selection matters enormously. An effect can be very clear on a biomarker and modest on a functional outcome.

That is why it is not correct to use a single indicator to conclude that the entire organism is responding in one particular way. Biology is multidimensional.

22. Biological dose is context-dependent

An exposure level has no universal biological meaning outside context. Molecule, formulation, route of administration, duration, concentration, tissue, biological sex, age, hormonal status, and the outcome being measured all matter. This is one of the foundations of individualized pharmacology.

23. Why the same person can respond differently at different times

The body's state changes. Sleep, energy availability, training volume, stress, inflammation, body composition, and organ function can modify pharmacological response. Identical exposure during a period of good recovery and during a period of high physiological stress should not automatically be assumed to have identical outcomes.

This is especially relevant in strength sport, where performance results from interactions between chronic adaptations and acute physiological state.

24. Why controlled studies matter so much

To identify a dose-response relationship, researchers have to control as many sources of variation as possible. In the Bhasin study, energy and protein intake were standardized, and endogenous testosterone production was suppressed before graded testosterone doses were given. This made the relationship between exposure and muscular changes easier to observe.

Such a design does not perfectly reproduce real life, but controlling variables helps isolate the pharmacological effect.

25. What a dose-response study does not tell us

A single study cannot automatically become a rule for every age, disease, sport, or substance. Study duration matters, population matters, route and formulation matter, and the measured endpoints matter.

Therefore, extrapolating from one study to an individualized use protocol is a methodological error. Research describes populations and estimated relationships; individual medical care requires clinical assessment, monitoring, and a risk-benefit profile.

26. Biological dose and the idea of a «responder»

Within the same population, some people have larger responses and others smaller responses to the same exposure. Genetic, hormonal, pharmacokinetic, and behavioral differences can contribute. The term responder is descriptively useful, but it should not become a simplistic explanation for every difference.

27. How this episode connects to the previous ones

The earlier episodes on the androgen receptor, anabolism and androgenism, pharmacokinetics, esterification, and metabolites describe different pieces of the same chain. The administered dose is the starting point. Pharmacokinetics determines concentration and exposure. Receptors and enzymes translate the signal into biological activity. Tissues and physiological adaptations determine the observable response.

The conceptual sequence is: dose → concentration → exposure → biological target → signal → adaptation → outcome. None of the arrows is perfectly linear.

28. What should a strongman remember?

The first idea is that the same dose does not automatically mean the same biological dose. The second is that exposure and concentration matter as much as the number of milligrams when trying to understand effects. The third is that response is not universal and does not follow the same curve for every body function.

For a strength athlete, it is especially important not to confuse a biomarker with performance and not to confuse greater exposure with a guarantee of a proportionally greater outcome. Likewise, the absence of symptoms does not mean the absence of biological change.

29. Conclusion: the body responds to exposure, not the number on the syringe

Pharmacology begins with dose, but it does not end there. The administered amount is transformed by absorption, distribution, metabolism, and elimination into an exposure profile. That exposure profile interacts with receptors, enzymes, and tissues, producing a response that can have thresholds, plateaus, delays, and individual differences.

In testosterone studies, dose-dependent relationships were observed for fat-free mass, muscle size, strength, power, and other variables, but not all functions followed the same curve. That is the central lesson: the body is not a reservoir where adding more substance automatically produces more performance. It is a dynamic system with limits, feedback, and multiple simultaneous responses.

Selected sources

Bhasin S et al. Testosterone dose-response relationships in healthy young men. American Journal of Physiology-Endocrinology and Metabolism. 2001;281:E1172-E1181. PMID: 11701431.

Bhasin S et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine. 1996;335:1-7. PMID: 8637535.

U.S. Food and Drug Administration. Clinical Pharmacology resources on exposure-response and Emax modeling.